The Filings Report

Illumina Inc

ILMNNasdaqCIK 1110803Healthcare / Diagnostics & Researchfiscal year ends December69 quarters since 2009

Revenue, Q2 FY2026
$1.2B
+9.4% on Q2 FY2025
Net income
$207M
−11.9% on Q2 FY2025
Free cash flow
$161M
−21.1% on Q2 FY2025
Diluted EPS
$1.35
−9.4% on Q2 FY2025
Revenue, TTM
$4.5B
trailing four quarters
Net margin, TTM
18.4%
net income $825M
Free cash flow, TTM
$931M
$1.1B less $164M capex
Cash and equivalents
—
long-term debt —, Jun 28, 2026
Shares, 12-month change
−1.8%
151M shares, Jun 28, 2026
Buybacks, TTM
$542M
1.5% of market value
Dividends, TTM
—
no yield
Market value
$35.6B
at the close, buybacks

Latest quarter Q2 FY2026, filed July 31, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q2 FY2026, the quarter ended June 28, 2026, Illumina Inc reported revenue of $1.2B, +9.4% on Q2 FY2025, and net income of $207M (−11.9%). Operating margin was 21.1%. Free cash flow, operating cash flow less capital expenditures, was $161M ($201M less $40M). Diluted earnings per share were $1.35.

The last 16 quarters

Q3 FY2022 to Q2 FY2026, through the filing of July 31, 2026.

Revenue and net incomeRevenueNet income
−$4B−$2B$0$2BQ3'22, Revenue: $1.1BQ3'22, Net income: −$3.8BQ3'22Q4'22, Revenue: $1.1BQ4'22, Net income: −$139MQ4'22Q1'23, Revenue: $1.1BQ1'23, Net income: $3MQ1'23Q2'23, Revenue: $1.2BQ2'23, Net income: −$234MQ2'23Q3'23, Revenue: $1.1BQ3'23, Net income: −$754MQ3'23Q4'23, Revenue: $1.1BQ4'23, Net income: −$176MQ4'23Q1'24, Revenue: $1.1BQ1'24, Net income: −$126MQ1'24Q2'24, Revenue: $1.1BQ2'24, Net income: −$2.0BQ2'24Q3'24, Revenue: $1.1BQ3'24, Net income: $705MQ3'24Q4'24, Revenue: $1.1BQ4'24, Net income: $186MQ4'24Q1'25, Revenue: $1.0BQ1'25, Net income: $131MQ1'25Q2'25, Revenue: $1.1BQ2'25, Net income: $235MQ2'25Q3'25, Revenue: $1.1BQ3'25, Net income: $150MQ3'25Q4'25, Revenue: $1.2BQ4'25, Net income: $334MQ4'25Q1'26, Revenue: $1.1BQ1'26, Net income: $134MQ1'26Q2'26, Revenue: $1.2BQ2'26, Net income: $207MQ2'26−$4B−$2B$0$2BQ3'22, Revenue: $1.1BQ3'22, Net income: −$3.8BQ4'22, Revenue: $1.1BQ4'22, Net income: −$139MQ4'22Q1'23, Revenue: $1.1BQ1'23, Net income: $3MQ2'23, Revenue: $1.2BQ2'23, Net income: −$234MQ2'23Q3'23, Revenue: $1.1BQ3'23, Net income: −$754MQ4'23, Revenue: $1.1BQ4'23, Net income: −$176MQ4'23Q1'24, Revenue: $1.1BQ1'24, Net income: −$126MQ2'24, Revenue: $1.1BQ2'24, Net income: −$2.0BQ2'24Q3'24, Revenue: $1.1BQ3'24, Net income: $705MQ4'24, Revenue: $1.1BQ4'24, Net income: $186MQ4'24Q1'25, Revenue: $1.0BQ1'25, Net income: $131MQ2'25, Revenue: $1.1BQ2'25, Net income: $235MQ2'25Q3'25, Revenue: $1.1BQ3'25, Net income: $150MQ4'25, Revenue: $1.2BQ4'25, Net income: $334MQ4'25Q1'26, Revenue: $1.1BQ1'26, Net income: $134MQ2'26, Revenue: $1.2BQ2'26, Net income: $207MQ2'26

Net income losses drawn in red.

Free cash flow
−$200M$0$200M$400MQ3'22, Free cash flow: −$118MQ3'22Q4'22, Free cash flow: $59MQ4'22Q1'23, Free cash flow: −$42MQ1'23Q2'23, Free cash flow: $58MQ2'23Q3'23, Free cash flow: $94MQ3'23Q4'23, Free cash flow: $173MQ4'23Q1'24, Free cash flow: $41MQ1'24Q2'24, Free cash flow: $49MQ2'24Q3'24, Free cash flow: $284MQ3'24Q4'24, Free cash flow: $335MQ4'24Q1'25, Free cash flow: $208MQ1'25Q2'25, Free cash flow: $204MQ2'25Q3'25, Free cash flow: $253MQ3'25Q4'25, Free cash flow: $266MQ4'25Q1'26, Free cash flow: $251MQ1'26Q2'26, Free cash flow: $161MQ2'26−$200M$0$200M$400MQ3'22, Free cash flow: −$118MQ4'22, Free cash flow: $59MQ4'22Q1'23, Free cash flow: −$42MQ2'23, Free cash flow: $58MQ2'23Q3'23, Free cash flow: $94MQ4'23, Free cash flow: $173MQ4'23Q1'24, Free cash flow: $41MQ2'24, Free cash flow: $49MQ2'24Q3'24, Free cash flow: $284MQ4'24, Free cash flow: $335MQ4'24Q1'25, Free cash flow: $208MQ2'25, Free cash flow: $204MQ2'25Q3'25, Free cash flow: $253MQ4'25, Free cash flow: $266MQ4'25Q1'26, Free cash flow: $251MQ2'26, Free cash flow: $161MQ2'26

Operating cash flow less capital expenditures; negative quarters in red.

Income statement

Last eight quarters, newest first, through Q2 FY2026 filed July 31, 2026.

Illumina Inc income statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 28, 2026filed Jul 31, 2026Q1 FY2026ended Mar 29, 2026filed May 4, 2026Q4 FY2025ended Dec 28, 2025filed Feb 12, 2026Q3 FY2025ended Sep 28, 2025filed Oct 31, 2025Q2 FY2025ended Jun 29, 2025filed Aug 1, 2025Q1 FY2025ended Mar 30, 2025filed May 9, 2025Q4 FY2024ended Dec 29, 2024filed Feb 12, 2025Q3 FY2024ended Sep 29, 2024filed Nov 6, 2024YoYQ2 FY2026vs Q2 FY2025
Revenue1,1591,0911,1591,0841,0591,0411,1041,080+9.4%
Cost of revenue389370400351364358376335+6.9%
Gross profit770721759733695683728745+10.8%
Research and development252240239229247252256253+2.0%
Selling, general and administrative273272309277234267279239+16.7%
Operating income245209201227214164175741+14.5%
Other income (expense)15(52)176(7)921812(21)−83.7%
Pretax income260157377220306182187720−15.0%
Income tax532343707151015−25.4%
Net income207134334150235131186705−11.9%
Diluted EPS ($)1.350.87—0.981.490.82—4.42−9.4%
Diluted shares (millions)153154—154157159—160—

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q2 FY2026 filed July 31, 2026.

Illumina Inc balance sheet, quarterly
Millions of dollarsQ2 FY2026ended Jun 28, 2026filed Jul 31, 2026Q1 FY2026ended Mar 29, 2026filed May 4, 2026Q4 FY2025ended Dec 28, 2025filed Feb 12, 2026Q3 FY2025ended Sep 28, 2025filed Oct 31, 2025Q2 FY2025ended Jun 29, 2025filed Aug 1, 2025Q1 FY2025ended Mar 30, 2025filed May 9, 2025Q4 FY2024ended Dec 29, 2024filed Feb 12, 2025Q3 FY2024ended Sep 29, 2024filed Nov 6, 2024YoYQ2 FY2026vs Q2 FY2025
Cash and equivalents—————————
Short-term investments128662152282211249370−42.1%
Total current assets2,8342,7383,2892,7962,6412,6732,7462,373+7.3%
Total assets6,6506,5596,6446,1776,0876,1826,3036,014+9.2%
Total current liabilities1,5781,5661,5851,9621,4611,4401,547975+8.0%
Long-term debt—————————
Total liabilities—————————
Stockholders’ equity2,8382,6762,7232,3812,2582,3682,3732,125+25.7%
Shares outstanding (millions)151151153153154158158159—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q2 FY2026 filed July 31, 2026.

Illumina Inc cash flow statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 28, 2026filed Jul 31, 2026Q1 FY2026ended Mar 29, 2026filed May 4, 2026Q4 FY2025ended Dec 28, 2025filed Feb 12, 2026Q3 FY2025ended Sep 28, 2025filed Oct 31, 2025Q2 FY2025ended Jun 29, 2025filed Aug 1, 2025Q1 FY2025ended Mar 30, 2025filed May 9, 2025Q4 FY2024ended Dec 29, 2024filed Feb 12, 2025Q3 FY2024ended Sep 29, 2024filed Nov 6, 2024YoYQ2 FY2026vs Q2 FY2025
Operating cash flow201289321284234240364316−14.1%
Capital expenditures4038553130322932+33.3%
Free cash flow (CFO − capex)161251266253204208335284−21.1%
Depreciation and amortization——666768697170—
Share repurchases128242421303702001799−65.4%
Dividends paid—————————

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 12, 2026.

Income statement

Illumina Inc income statement, annual
Millions of dollarsFY2025ended Dec 28, 2025filed Feb 12, 2026FY2024ended Dec 29, 2024filed Feb 12, 2025FY2023ended Dec 31, 2023filed Feb 16, 2024FY2022ended Jan 1, 2023filed Feb 17, 2023FY2021ended Jan 2, 2022filed Feb 18, 2022FY2020ended Jan 3, 2021filed Feb 17, 2021FY2019ended Dec 29, 2019filed Feb 11, 2020FY2018ended Dec 30, 2018filed Feb 12, 2019FY2017ended Dec 31, 2017filed Feb 13, 2018FY2016ended Jan 1, 2017filed Feb 14, 2017FY2015ended Jan 3, 2016filed Mar 2, 2016FY2014ended Dec 28, 2014filed Feb 18, 2015FY2013ended Dec 29, 2013filed Feb 18, 2014FY2012ended Dec 30, 2012filed Feb 15, 2013FY2011ended Jan 1, 2012filed Feb 24, 2012FY2010ended Jan 2, 2011filed Feb 28, 2011FY2009ended Jan 3, 2010filed Aug 4, 2010FY2008ended Dec 28, 2008filed Aug 4, 2010
Revenue4,3434,3724,5044,5844,5263,2393,5433,3332,7522,3982,2201,8611,4211,1491,056903666573
Cost of revenue1,4731,5111,7601,6121,3721,0361,0761,033926732671564509375346301212220
Gross profit2,8702,8612,7442,9723,1542,2032,4672,3001,8261,6661,5491,298912774709602454353
Research and development9671,1691,3541,3211,185682647623546504401388277231197178141100
Selling, general and administrative1,0861,0921,6121,2972,092941835794674584516466381286262220176148
Operating income807(833)(1,069)(4,179)(123)58098588360658761351513420119921212680
Other income (expense)279(346)(48)(157)1,00727613311437(26)(30)(66)2522(66)(26)(11)(8)
Pretax income1,086(1,179)(1,117)(4,336)8848561,1188941,04356158344915922313318511473
Income tax23644446812220012811236513312595347146604233
Net income850(1,223)(1,161)(4,404)7626561,002826726463462353125151871257239
Diluted EPS ($)5.45(7.69)(7.34)(28.00)5.044.456.745.564.923.073.102.370.901.130.620.870.530.30
Diluted shares (millions)156159158157151148149149148148149149140134139143137134

Balance sheet

Illumina Inc balance sheet, annual
Millions of dollarsFY2025ended Dec 28, 2025filed Feb 12, 2026FY2024ended Dec 29, 2024filed Feb 12, 2025FY2023ended Dec 31, 2023filed Feb 16, 2024FY2022ended Jan 1, 2023filed Feb 17, 2023FY2021ended Jan 2, 2022filed Feb 18, 2022FY2020ended Jan 3, 2021filed Feb 17, 2021FY2019ended Dec 29, 2019filed Feb 11, 2020FY2018ended Dec 30, 2018filed Feb 12, 2019FY2017ended Dec 31, 2017filed Feb 13, 2018FY2016ended Jan 1, 2017filed Feb 14, 2017FY2015ended Jan 3, 2016filed Mar 2, 2016FY2014ended Dec 28, 2014filed Feb 18, 2015FY2013ended Dec 29, 2013filed Feb 18, 2014FY2012ended Dec 30, 2012filed Feb 15, 2013FY2011ended Jan 1, 2012filed Feb 24, 2012FY2010ended Jan 2, 2011filed Feb 28, 2011FY2009ended Jan 3, 2010filed Aug 4, 2010FY2008ended Dec 28, 2008filed Aug 4, 2010
Cash and equivalents———————1,1441,225735769636712434303249145327
Short-term investments215936261071,6621,3722,368920824617702454916887645549—
Total current assets3,2892,7462,6093,5612,7134,4834,4514,4902,9802,3182,0971,8901,6181,7871,5451,258982—
Total assets6,6446,30310,11112,25215,2177,5857,3166,9595,2574,2813,6883,3403,0192,5662,1961,8391,430—
Total current liabilities1,5851,5471,5702,7731,0931,2446651,804746705610722322305227535441—
Long-term debt—————6731,1418381,1821,0561,016987——————
Total liabilities——————————————————
Stockholders’ equity2,7232,3735,7456,59910,7404,6944,6133,7582,7492,1971,8491,4631,5331,3191,0751,198864799
Shares outstanding (millions)153158159158157146147147147146147144128124122128——

Cash flow statement

Illumina Inc cash flow statement, annual
Millions of dollarsFY2025ended Dec 28, 2025filed Feb 12, 2026FY2024ended Dec 29, 2024filed Feb 12, 2025FY2023ended Dec 31, 2023filed Feb 16, 2024FY2022ended Jan 1, 2023filed Feb 17, 2023FY2021ended Jan 2, 2022filed Feb 18, 2022FY2020ended Jan 3, 2021filed Feb 17, 2021FY2019ended Dec 29, 2019filed Feb 11, 2020FY2018ended Dec 30, 2018filed Feb 12, 2019FY2017ended Dec 31, 2017filed Feb 13, 2018FY2016ended Jan 1, 2017filed Feb 14, 2017FY2015ended Jan 3, 2016filed Mar 2, 2016FY2014ended Dec 28, 2014filed Feb 18, 2015FY2013ended Dec 29, 2013filed Feb 18, 2014FY2012ended Dec 30, 2012filed Feb 15, 2013FY2011ended Jan 1, 2012filed Feb 24, 2012FY2010ended Jan 2, 2011filed Feb 28, 2011FY2009ended Jan 3, 2010filed Aug 4, 2010FY2008ended Dec 28, 2008filed Aug 4, 2010
Operating cash flow1,0798374783925451,0801,0511,14287577978650138629235827317288
Capital expenditures148128195286208189209296310260143106796978505360
Free cash flow (CFO − capex)93170928310633789184284656551964339530722328022312028
Depreciation and amortization270354432394251187188179156141127113——————
Share repurchases74211600073632420125124927423750835704417571
Dividends paid——————————————————

Insider activity

Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$436M
68 sales by 2 insiders; officers and directors $436M
Bought, twelve months
$85K
2 purchases by 1 insider; officers and directors $85K
Sold, twelve months
$593M
112 sales by 5 insiders; officers and directors $593M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 5, 2026Thaysen JacobChief Executive Officer, Directortax withholding1,303$293.69$383K107,770Oct 7, 2026
Sep 30, 2026Meister Keith A.Directoraward107$219.80$24K6,887Oct 2, 2026
Sep 30, 2026Ullem Scott B.Directoraward113$219.80$25K11,143Oct 2, 2026
Sep 8, 2026Coletti Julie AnnChief Legal Officeraward4,549$0.00—4,549Sep 10, 2026
Sep 8, 2026Coletti Julie AnnChief Legal Officeraward14,214$0.00—18,763Sep 10, 2026
Sep 5, 2026Barnard StevenSVP, Chief Technology Officertax withholding408$211.06$86K40,927Sep 9, 2026
Sep 4, 2026Meister Keith A.Directoropen-market saleindirect7,500$217.28$2M882,351Sep 4, 2026
Sep 4, 2026Meister Keith A.Directoropen-market saleindirect100,650$218.39$22M781,701Sep 4, 2026
Sep 4, 2026Meister Keith A.Directoropen-market saleindirect11,351$219.18$2M770,350Sep 4, 2026
Sep 3, 2026Meister Keith A.Directoropen-market saleindirect8,439$215.20$2M957,363Sep 4, 2026
Sep 3, 2026Meister Keith A.Directoropen-market saleindirect13,261$216.38$3M944,102Sep 4, 2026
Sep 3, 2026Meister Keith A.Directoropen-market saleindirect14,196$217.29$3M929,906Sep 4, 2026
Sep 3, 2026Meister Keith A.Directoropen-market saleindirect9,721$218.33$2M920,185Sep 4, 2026
Sep 3, 2026Meister Keith A.Directoropen-market saleindirect13,717$219.41$3M906,468Sep 4, 2026
Sep 3, 2026Meister Keith A.Directoropen-market saleindirect6,656$220.17$1M899,812Sep 4, 2026
Sep 3, 2026Meister Keith A.Directoropen-market saleindirect9,961$221.55$2M889,851Sep 4, 2026
Sep 2, 2026Meister Keith A.Directoropen-market saleindirect57,488$213.20$12M976,422Sep 4, 2026
Sep 2, 2026Meister Keith A.Directoropen-market saleindirect10,620$213.73$2M965,802Sep 4, 2026
Aug 27, 2026Meister Keith A.Directoropen-market saleindirect4,873$226.74$1M1MAug 27, 2026
Aug 27, 2026Meister Keith A.Directoropen-market saleindirect54,309$227.67$12M1MAug 27, 2026
Aug 27, 2026Meister Keith A.Directoropen-market saleindirect24,363$228.64$6M1MAug 27, 2026
Aug 27, 2026Meister Keith A.Directoropen-market saleindirect16,990$229.72$4M1MAug 27, 2026
Aug 27, 2026Meister Keith A.Directoropen-market saleindirect28,439$230.54$7M1MAug 27, 2026
Aug 27, 2026Meister Keith A.Directoropen-market saleindirect9,405$231.23$2M1MAug 27, 2026
Aug 26, 2026Meister Keith A.Directoropen-market saleindirect38,213$224.72$9M1MAug 27, 2026

Full insider history for Illumina Inc, or insider activity across all companies. A record of filings, not a recommendation.

Tracked funds holding it

1 of the tracked managers held ILMN in their latest 13F filing, through August 14, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded ILMN by quarter.

FundManagerQuarterValueSharesWeightMove
Baron Capital GroupRon BaronQ2 2026$40M227,0940.06%added +3.5%

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
ILLUMINA, INC., CIK 1110803 on EDGAR
Extract generated
October 6, 2026
Withheld
1 line-years whose four quarters do not sum to the filed year: buybacks FY2012
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax, SalesRevenueNet
Cost of revenue: CostOfGoodsAndServicesSold, CostOfRevenue
Gross profit: GrossProfit
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): NonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: ShortTermInvestments
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebt, LongTermDebtNoncurrent
Total liabilities: not filed
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: not filed

The data

The statements on this page as files, generated October 6, 2026.

JSON file
/data/financials/ILMN.json